title: Is there any potential for first-line etravirine use? Analysis from a large data set of antiretroviral therapy-naive HIV-infected patients undergoing resistance test.
authors.forename: Mauro
authors.initials: M
authors.lastname: Zaccarelli
authors.forename: Andrea
authors.initials: A
authors.lastname: Antinori
authors.forename: Alessandro
authors.initials: A
authors.lastname: Cozzi-Lepri
authors.forename: Cristina
authors.initials: C
authors.lastname: Mussini
authors.forename: Guido
authors.initials: G
authors.lastname: Palamara
authors.forename: Maria Mercedes
authors.initials: MM
authors.lastname: Santoro
authors.forename: Vincenso
authors.initials: V
authors.lastname: Spagnuolo
authors.forename: Antonella d'Arminio
authors.initials: Ad
authors.lastname: Monforte
authors.forename: Carlo Federico
authors.initials: CF
authors.lastname: Perno
authors.forename: Francesca
authors.initials: F
authors.lastname: Ceccherini-Silberstein
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D024882:Drug Resistance, Viral / Q000187:drug effects / Q000235:genetics / Q000502:physiology*; D005260:Female; D006678:HIV / Q000187:drug effects* / Q000235:genetics; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009154:Mutation / Q000187:drug effects / Q000235:genetics* / Q000502:physiology; D009570:Nitriles; D011724:Pyridazines / Q000627:therapeutic use*; D011743:Pyrimidines; D055815:Young Adult
chemical_list: D009570:Nitriles; D011724:Pyridazines; D011743:Pyrimidines; C451734:etravirine